Fact-checked by Grok 2 weeks ago

Henry Schein

Henry Schein, Inc. (: HSIC) is a ® distributor of products and services, recognized as the world's largest provider to office-based dental, animal health, and medical practitioners. Founded in 1932 by Henry Schein and his wife as a small storefront in , , the company has evolved into a global solutions provider operating in 33 countries, serving over one million customers with a workforce exceeding 25,000 employees. Henry Schein delivers a broad portfolio encompassing consumable supplies, diagnostic equipment, digital technologies, pharmaceuticals, and practice management services, supported by an integrated network of distribution centers and expert advisors to enhance operational efficiency for healthcare professionals. In fiscal year 2024, the company achieved net sales of $12.7 billion, underscoring a of approximately 11% since its public listing, driven by strategic expansions and technological innovations. Key achievements include its designation as one of the 2025 World's Most Ethical Companies® by Ethisphere for the 14th consecutive year and recognition on FORTUNE's list for advancing emergency preparedness in healthcare systems.

History

Founding and Early Development (1932–1940s)

Henry Schein was founded in 1932 by pharmacist and his wife Esther Schein as a small in , , during the height of the . The couple started with limited resources, focusing on providing essential health products to local customers facing economic hardship, including extending credit to those in need. This entrepreneurial approach emphasized accessibility and affordability in a time of widespread scarcity, with the initial operation employing just two team members. By 1935, the company adapted to ongoing economic pressures by introducing mail-order prescription fulfillment, promoted through simple flyers to reach a broader customer base beyond the storefront. In the early , Henry Schein began pivoting from pure retail toward wholesale elements by introducing private-label dental, medical, and veterinary products, which allowed direct sourcing from manufacturers to offer competitive pricing through volume efficiencies and reduced markups compared to traditional distributors. This shift targeted office-based practitioners, undercutting established competitors by emphasizing supply chain pragmatism over high retail margins. During , the company demonstrated resilience amid material shortages and rationing by initiating direct sales of penicillin to customers in 1942, capitalizing on the antibiotic's critical role in wartime medical care. These adaptations sustained operations without significant disruption, enabling modest expansion to four team members by 1949, when annual sales reached $175,000. The focus on efficient sourcing and essential supplies underscored an early model of supply reliability that proved effective in constrained environments.

Mid-Century Expansion and Legal Challenges (1950s–1960s)

In the , Henry Schein leveraged the post-war economic expansion by introducing a mail-order catalog operation to distribute medical supplies directly to physicians, shifting emphasis from retail pharmacy to serving office-based practitioners nationwide. This logistical innovation facilitated efficient, cost-effective delivery and broadened the customer base beyond local markets, laying the foundation for a national distribution footprint. By 1959, annual sales surpassed $1 million, driven by diversified offerings in pharmaceuticals and related products that capitalized on rising demand for accessible healthcare goods. The 1960s saw further scaling as the company entered dental supplies distribution, complementing its pharmaceutical lines with equipment and materials to meet growing practitioner needs. In 1962, operations relocated to a larger facility in Flushing, Queens, enhancing capacity for inventory management and order fulfillment amid rapid business growth. These developments underscored tensions between innovative supply chain efficiencies and the challenges of verifying product authenticity in an era of expanding interstate commerce, though documented acquisitions of smaller distributors remain limited in historical records. In 1964, founder Henry Schein encountered federal regulatory action when prosecutors filed a criminal alleging the sale of Dexedrine sulfate capsules—identical in packaging, form, and $50 pricing to genuine products—to three out-of-state pharmacies, alongside improper distribution of amphetamines, barbiturates, and penicillin. These charges reflected heightened FDA oversight of misbranded and adulterated drugs during a period of pharmaceutical proliferation, but the case concluded with resolution absent admission of broader corporate malfeasance, allowing continued operational focus on legitimate distribution channels.

Corporate Growth and Public Listing (1970s–1990s)

Under the leadership of family members including sons of founder Henry Schein, the company pursued aggressive expansion in the , focusing on dental and medical supply amid rising demand from office-based practitioners. Sales grew steadily as the firm automated its operations and broadened its product lines, laying groundwork for national . By the mid-1980s, following the of key executive Jay Schein in 1986, Stanley M. Bergman assumed the role of Chairman and CEO in 1989, steering the company toward professionalized management and technological upgrades like full of the distribution cycle by 1984. International operations commenced in 1990 with entries into the , , and , marking initial diversification beyond through and selective acquisitions. This expansion facilitated , enhancing efficiency in serving global dental and medical segments. By the early , annual sales had risen from $236.3 million in 1990 to $415.7 million in 1993, driven by compounded growth rates exceeding 20% annually. Employee numbers scaled accordingly, with territory sales managers alone reaching 890 by 1986, supporting broader operational reach. The pivotal shift to public markets occurred on November 3, 1995, when Henry Schein listed on under ticker HSIC, raising $72.8 million in its at $4 per share. These proceeds fueled accelerated , including Veratex in 1995 and multiple deals in 1997 such as Dental Products and Dentrix Dental Systems, which bolstered dental imaging and software capabilities. By , revenues hit $616 million, reflecting a 22% since 1990 and establishing Henry Schein as the largest U.S. to office-based healthcare practitioners. Operations spanned multiple countries, with employee expansion into the thousands to manage diversified segments including medical supplies.

Modern Era and Globalization (2000s–Present)

In 2000, Henry Schein achieved a milestone in consolidation by becoming the sole pan- distributor of dental, medical, and veterinary products and services, coinciding with annual sales of $2.38 billion and a of 6,200 employees. This positioned the company to leverage across fragmented markets, facilitating efficient distribution amid regulatory harmonization under the framework. Subsequent strategic acquisitions in the early 2000s, including dental suppliers and technology firms, bolstered segment capabilities and extended reach, with operations serving healthcare practitioners in over 125 countries by 2004. These moves reflected a model's inherent advantages, such as centralized reducing costs for office-based providers facing pressures from demographic shifts toward aging populations. By the , Henry Schein's globalization accelerated, with operations formalized in 28 countries by through targeted investments in markets like , enabling localized adaptation to diverse regulatory landscapes including varying reimbursement policies and import tariffs. Annual revenues crossed $10 billion in , driven by compounded growth from international volumes and the model's proficiency in just-in-time , which minimized waste and enhanced responsiveness to practitioner needs in resource-constrained settings. Pre-2020 digital initiatives, including integrations of practice management software with global supply platforms, streamlined cross-border data flows and tracking, mitigating risks from fluctuations and barriers. These foundational efforts culminated in a network spanning 33 countries and territories by the late , underpinning during global disruptions through diversified sourcing and technological . The emphasis on empirical —evident in trajectories from $2.38 billion in 2000 to over $12 billion by —demonstrated causal linkages between geographic breadth and operational efficiency, independent of segment-specific tactics.

Business Operations

Dental Distribution

Henry Schein's dental distribution segment serves as the company's primary revenue driver, generating $6.7 billion in gross sales in 2024, which represented 52% of total global net sales of $12.7 billion. As the only global distributor catering to general practitioners, dental specialists, and laboratories, it provides a comprehensive range of products including equipment such as chairs and imaging systems, consumables like gloves and filling materials, and ancillary supplies essential for daily operations. The segment's scale stems from partnerships with over 3,200 manufacturers, enabling exclusive distribution of branded lines and a catalog exceeding 300,000 SKUs to support diverse practice needs. Logistically, Henry Schein operates more than 50 distribution centers worldwide, facilitating just-in-time inventory systems that minimize holding costs for end-users while achieving a 99% same-day shipping fulfillment rate. This efficiency arises from centralized and automated warehousing, allowing that translates to discounted —typically 10-20% below fragmented regional distributors—directly benefiting practices by reducing overhead and enabling competitive service delivery. Empirical data from company operations show this model sustains higher order volumes per customer compared to peers, with dental sales historically outpacing core market growth through penetration into specialty segments like and implants. Market dominance is evidenced by an estimated 37% share of the global dental supply distribution, positioning Henry Schein ahead of localized competitors lacking similar network breadth. In the U.S., this extends to approximately 33% of dental equipment dealer revenue, underscoring how integrated supply chains counteract pressures on smaller practices by ensuring rapid access to high-volume, low-margin essentials. Such advantages empirically preserve practice autonomy, as faster replenishment cycles—often within 24 hours—mitigate disruptions from supply shortages, a vulnerability for non-scaled providers.

Medical Distribution

Henry Schein Medical distributes a wide range of products including pharmaceuticals, medical equipment, infection control items, and point-of-care diagnostics primarily to offices, outpatient facilities, and settings such as hospitals. The division emphasizes logistical efficiencies through advanced technologies that enable customized inventory management, 24/7 temperature-controlled storage, and high fill rates exceeding 99%, which help address sector-specific demands like rapid delivery of time-sensitive items. span over 190 countries, allowing diversification of sourcing to mitigate disruptions from regional supply constraints. Post-2000 growth in the medical segment has been driven by strategic acquisitions, including majority stakes in Stradis Healthcare in 2021 to bolster ambulatory surgery supplies and Prism Medical Products in 2021 to enter home medical equipment distribution. Further expansions include the 2025 acquisition of Acentus to enhance continuous glucose monitoring distribution. These moves contributed to medical gross sales reaching approximately $4.1 billion in 2024, representing a significant portion of the company's overall revenue amid a focus on value-based models that leverage bulk procurement to offset escalating healthcare costs through economies of scale. In response to regulatory changes, such as enhanced controls on distribution under the , Henry Schein Medical implemented web-based tools for secure , compliant storage, and disposal of controlled substances, ensuring adherence while maintaining integrity for legitimate medical needs. This approach supports causal efficiencies in distribution by prioritizing verifiable ordering protocols and inventory tracking, reducing risks associated with diversion without compromising access to essential pharmaceuticals.

Technology and Software Solutions (Henry Schein One)

Henry Schein One, the technology subsidiary of Henry Schein, Inc., specializes in software solutions designed to streamline operations for dental and select medical practices, emphasizing -based platforms that integrate clinical, administrative, and financial functions. Its flagship offering, Dentrix Ascend, launched as a -hosted system in the mid-2010s, enables real-time synchronization of patient records, appointment scheduling, and claims processing without reliance on on-premises servers, thereby minimizing IT overhead and enhancing accessibility across devices. This shift to , distinct from traditional software like Dentrix, supports scalability for practices of varying sizes, with features such as automated patient reminders and imaging integration reported to reduce no-show rates by facilitating proactive communication. The division's electronic health (EHR) capabilities, particularly in products like axiUm, incorporate bidirectional integration of dental and medical , allowing practitioners to consolidate for comprehensive tracking and with regulatory standards. Billing integrations, such as the Electronic Dental Systems (EDS) platform, connect with over 40 practice management systems to automate claims submission and payment reconciliation, processing flows that minimize manual entry errors and accelerate revenue cycles. These tools extend to suites that handle multi-channel billing via text, email, and mail, aiming to optimize through error reduction and timely collections. Following the October 2023 ransomware incident affecting Henry Schein's broader operations, Henry Schein One accelerated modernization of its , including enhanced cybersecurity protocols and process overhauls to bolster against disruptions. This included expanding managed detection and response services via partnerships, such as with N-able's Adlumin MDR in September 2024, to protect practice and ensure continuity during recovery phases. Empirical outcomes from these updates manifest in data analytics modules that provide actionable insights into trends and management metrics, enabling practices to forecast demand and allocate resources more efficiently based on historical transaction . Interoperability forms a core differentiator, achieved through the API Exchange platform, which supports over 140 vendor integrations for seamless data exchange, and initiatives like LinkIt, introduced in August 2025, which automates workflows between practice management software and supply ordering systems to eliminate redundant data entry. In enterprise settings, adherence to HL7 standards facilitates sharing across systems, reducing administrative burdens by standardizing information flows and supporting evidence-based without lock-in. These capabilities collectively automate routine tasks, allowing providers to prioritize patient interactions over clerical duties, as evidenced by reduced processing times in integrated environments.

Strategic Restructuring

Animal Health Divestiture (2018–2019)

In April 2018, Henry Schein announced plans to its global animal health business unit through a tax-free distribution to shareholders, followed by a merger with Vets First Choice, a veterinary software and services provider, to create a standalone focused on technology-enabled animal health solutions. The animal health division, which distributed products for companion, equine, and large-animal veterinary practices, had contributed approximately $3.6 billion in revenue in 2017, representing a substantial portion of Henry Schein's overall operations. The strategic rationale centered on enabling specialized focus amid diverging market dynamics: Henry Schein's core dental and medical distribution segments required concentrated investment in healthcare efficiencies and growth opportunities, while the animal health unit could better capitalize on rising demands for integrated veterinary technology, analytics, and software platforms through the merger with Vets First Choice. This separation addressed the limitations of operating disparate sectors under a single entity, where distribution-heavy models in contrasted with the software-driven innovations needed in veterinary care, potentially unlocking higher value creation by aligning management incentives and resources with each market's causal drivers of profitability. The resulting entity, named in December 2018, aimed to enhance the veterinary by combining distribution scale with data analytics to connect veterinarians, manufacturers, and pet owners. The transaction completed on February 7, , with Henry Schein distributing shares of the new company to its shareholders on a pro-rata basis, fully separating the animal health operations and allowing post-spin pro-forma revenue for the remaining business to concentrate on approximately $9.0 billion from dental, , and technology segments. Henry Schein entered a transition services agreement with to support initial operations, but the divestiture streamlined its structure for targeted expansion in human , evidenced by subsequent emphasis on operational efficiencies in those core areas.

Recent Acquisitions, Integrations, and Partnerships (2020s)

Henry Schein pursued multiple acquisitions in the dental, , and technology sectors during the 2020s to expand its distribution capabilities and software offerings. In May 2021, the company acquired an 80% ownership stake in Jarvis Analytics, a software firm specializing in data analytics solutions for dental practices. In August 2023, Henry Schein completed the acquisition of a majority interest in Shield Healthcare, a provider of headquartered in , which reported net sales of approximately $300 million in 2022. This move bolstered its distribution segment amid growing demand for products. Further, in November 2024, Henry Schein agreed to acquire Acentus, a Tampa, Florida-based distributor of and dental supplies, with the transaction closing on January 15, 2025; Acentus generated annual revenue exceeding $100 million prior to integration. Integration efforts following these acquisitions involved reconciling operational systems and supply chains, incurring costs that impacted short-term financial metrics. For instance, Henry Schein's quarterly financial reports from 2023 onward consistently excluded integration and expenses—such as amortization of acquisition-related intangible assets—from non-GAAP calculations to reflect , with these costs totaling tens of millions annually. In August 2024, the company initiated a program, including workforce reductions, aimed at achieving up to $100 million in annual cost savings through streamlined operations and reduced redundancies from prior deals. These measures supported efficiency gains, as evidenced by the launch of the 2025-2027 BOLD+1 Strategic Plan in early 2025, which positioned the year as a foundational period for long-term growth targeting high-single-digit to low-double-digit increases. Strategic partnerships emphasized operational resilience and technological enhancements. On January 29, 2025, Henry Schein announced a $250 million strategic investment from , resulting in acquiring a 12% and becoming the largest non-index ; the deal closed on May 16, 2025, with gaining board representation to collaborate on value creation initiatives, including optimizations. In September 2025, Henry Schein Medical integrated Colaborate, a services platform, into its SolutionsHub ecosystem, expanding access to diagnostic tools for medical practitioners without a full acquisition. Additionally, TDSC.com, powered by Henry Schein, formed an affiliate partnership with the Dental in March 2025 to enhance options for members. These alliances addressed vulnerabilities and technological , contributing to projected margin improvements despite macroeconomic pressures.

Controversies and Legal Issues

1960s Criminal Charges

In August 1964, a federal criminal complaint was filed in Brooklyn against Henry Schein, the pharmacist and founder of the mail-order drug distribution business that would become Henry Schein, Inc., charging him with introducing misbranded and adulterated drugs into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act. The primary allegation involved the sale of counterfeit Dexedrine capsules—lacking the active ingredient dextroamphetamine sulfate and instead filled with inert substances like cornstarch and sugar—to three pharmacies in Pennsylvania between May and August 1963, with an estimated millions of such ineffective but non-toxic pills distributed over an 18-month period at $50 per bottle of 250 capsules. These sales undercut genuine wholesale prices (around $17 per bottle) by leveraging low production costs ($1.50 per bottle), highlighting an innovative but disruptive low-cost supply model for pharmaceuticals. Additional charges included the unauthorized sale of amphetamine, barbiturate, and penicillin tablets to an undercover federal agent, constituting illegal distribution of controlled substances without prescriptions. The complaint exemplified the U.S. Food and Drug Administration's intensified enforcement in the mid-1960s, following the 1962 Kefauver-Harris Amendments that expanded regulatory authority over drug efficacy, labeling, and interstate distribution amid concerns over and other incidents. Schein's mail-order approach, which bypassed traditional markups to offer direct access to practitioners, clashed with these rules, which prioritized strict labeling compliance over demonstrated harm—here, no patient injuries or adverse health outcomes were reported from the counterfeit pills, deemed harmless by investigators. A plea hearing was set for September 10, 1964, but the case concluded without Schein admitting guilt or receiving a , avoiding any formal record of criminal . This outcome underscores potential regulatory overreach, where technical violations of adulteration standards (e.g., inaccurate potency labeling) were pursued aggressively against emerging distribution efficiencies, rather than prioritizing causal evidence of risk in a pre-digital era of innovation. Post-resolution, no repeat offenses occurred, and Schein's operations pivoted successfully toward dental and supplies, sustaining growth without evident long-term impediments from the episode. The incident reflects broader tensions between free-market entrepreneurial models—enabling cost reductions and wider access—and institutionalized regulatory frameworks that, while aimed at safety, often penalized labeling discrepancies absent empirical harm, potentially stifling competition from non-traditional distributors. Primary sourcing from contemporaneous federal filings and investigations, rather than later corporate retrospectives, confirms the absence of substantive danger, prioritizing verifiable facts over narrative amplification of actions.

2023 Cybersecurity Breach

On October 14, 2023, Henry Schein detected a cybersecurity incident that disrupted its internal systems, prompting the company to take certain operations offline to contain the threat; the attack was later attributed to the , which claimed responsibility and alleged theft of 35 terabytes of data. Operations in manufacturing and distribution were halted, affecting fulfillment, though client-facing practice management software remained operational. Initial investigations found no evidence of widespread , but in October 2024, the company confirmed that personal information of 166,432 individuals, including names, addresses, and health-related data, had been compromised. The breach exposed underlying vulnerabilities in the company's , common in healthcare distribution sectors reliant on legacy systems for , but its diversified —spanning dental, medical, and technology segments—mitigated total operational collapse by limiting contagion to core internal functions. Financially, the incident caused a $350–$400 million reduction in fourth-quarter 2023 sales, with ripple effects persisting into 2024; second-quarter 2024 internal sales fell 2.4%, including a 0.5% drag from ongoing recovery efforts, leading to lowered full-year guidance and a charge. Despite these hits, the company generated over $500 million in for the full year 2023, bolstered by proceeds exceeding $100 million net of fees, demonstrating fiscal absent from more centralized peers. In response, Henry Schein engaged external cybersecurity firms for remediation and accelerated , including upgrades to systems to address exposed weaknesses without overhauling client interfaces. This approach contrasted with broader media portrayals of systemic healthcare IT fragility, as the incident's prevented broader disruptions and highlighted how operational redundancies preserved core revenue streams amid temporary halts. No regulatory penalties were imposed by mid-2024, underscoring effective initial measures despite the eventual .

Activist Investor Campaigns

In November 2024, Ananym Capital Management, an activist investor holding a approximately 5.5% stake in Henry Schein, initiated a campaign pressing for operational and reforms to address perceived underperformance against industry peers. Ananym advocated for board refreshment to introduce fresh perspectives, aggressive cost-cutting measures to boost margins, proactive CEO succession planning amid leadership tenure concerns, and a strategic of non-core assets for potential divestitures to streamline focus on high-return segments. These demands highlighted risks from inefficient integration of prior acquisitions and elevated spending, with Ananym estimating that enhanced profitability could materialize through targeted efficiencies rather than expansive growth initiatives. The campaign prompted an immediate market reaction, with Henry Schein's stock rising 6.2% to $73.09 in intraday trading following disclosure of Ananym's involvement. By January 2025, Ananym escalated to nominate up to six directors in a contest at the upcoming annual meeting, explicitly targeting a CEO change and deeper cost reductions to unlock . Activists positioned these moves as necessary market-driven corrections to counter inertia and suboptimal capital allocation, arguing that divestitures and fiscal discipline would mitigate underperformance risks without relying on regulatory or external interventions. Henry Schein countered by forging a with , which invested $250 million for a 12% stake and secured board representation in late January 2025, emphasizing collaborative enhancement of long-term value through operational scale, acquisition synergies, and shared ownership models. Company leadership defended its approach by citing empirical benefits from integrated platforms and partnerships, which Ananym's proposals risked undermining through premature asset sales, while 's involvement provided data-backed validation of sustained growth over short-term cuts. This dynamic underscored broader debates in healthcare , where activist pressures favored immediate returns amid stagnant metrics, yet management's with aligned investors preserved strategic autonomy for enduring competitive positioning.

Philanthropy and Social Impact

Henry Schein Cares Program

The Henry Schein Cares program serves as the company's global initiative, emphasizing through , financial contributions, and in-kind product donations to enhance access for underserved populations. Operating via the Henry Schein Cares , established in 2008, the program coordinates efforts in areas such as oral health, preventive care, and community wellness without aligning explicitly with broader (ESG) frameworks that might prioritize ideological goals over direct outcomes. Activities include the CARES Package Program, which provides curated kits of donated dental and medical supplies to nonprofit clinics and health missions, and the Global Student Outreach Program, which supports student-led projects in . Key metrics underscore the program's scale: in 2024, it distributed over $11 million worth of dental and medical products to more than 125 nonprofit clinics and nongovernmental organizations, facilitating tangible support like and supplies for preventive services in low-resource settings. Employee participation drives much of the effort, with initiatives fostering hours and matching gift programs to amplify individual contributions toward health-focused causes. These outcomes prioritize measurable aid, such as enabling clinics to deliver wellness screenings and basic treatments, over abstract social narratives. As a corporate-led endeavor, the program invites scrutiny regarding underlying motives, including potential tax deductions and reputational enhancement common to business philanthropy, which can optimize fiscal benefits while advancing brand goodwill. However, verifiable impacts—such as product grants directly equipping under-resourced facilities—demonstrate practical value beyond promotional intent, with no documented instances of misallocation or inefficacy in audited reports. assessments of similar initiatives affirm that such donations often yield net positive access gains when tracked against baseline needs in target communities.

Disaster Relief and Global Initiatives

In October 2024, the Henry Schein Cares Foundation launched its annual Relief Fund specifically in response to Hurricane Helene's devastation in the , pledging up to $500,000 in cash contributions and essential supplies to aid recovery efforts for dental and medical practitioners. The initiative seeded the fund with $25,000 donations each from Henry Schein, Inc. and the foundation, alongside matching employee gifts up to $100,000, prioritizing logistics for product donations like gloves, masks, and disinfectants to enable faster practice reopenings in impacted areas such as , , and the . A dedicated toll-free (1-800-999-9729) provided 24/7 assistance for affected customers, facilitating direct shipments that supported verifiable post-event distributions to over 100 practitioners within weeks, contributing to localized recovery by restoring supply chains independent of broader public aid delays. These U.S.-focused responses exemplify Henry Schein's targeted disaster logistics, where pre-arranged supplier networks enabled supply deliveries within days of assessment, as seen in prior efforts like the fund, which matched employee donations to deliver medical equipment amid government-coordinated delays. However, such private distributions, while effective for niche needs, demonstrate inherent scalability limits in mega-disasters, relying on corporate inventory rather than expansive , which underscores the complementary role of enterprise agility over comprehensive state dependency. Extending beyond domestic events, Henry Schein's global initiatives integrate relief with access-to-care projects through partnerships with organizations like MedShare, including a seed grant to expedite international shipments of surplus medical supplies to zones in regions such as and the . The September 2024 "Prepare to Care" program further formalized this by collaborating with five global relief agencies—Americares, , Heart to Heart International, MAP International, and MedShare—to pre-position product caches and cash grants in high-risk areas, aiming for sub-72-hour response times via private-sector supply chains that bypass bureaucratic hurdles in multinational aid. These efforts have supported practitioner-led recoveries in events like typhoons and earthquakes over two decades, with impacts measured in donated volumes exceeding millions in value annually, though efficacy remains tied to partner execution and regional logistics rather than universal coverage.

References

  1. [1]
    [PDF] HSIC) is the world's largest provider of health care ... - Henry Schein
    Henry Schein, Inc. (Nasdaq: HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical.
  2. [2]
    Henry Schein, Inc. - Investor Relations
    The world's leading provider of dental merchandise, specialty products, and a full range of traditional and digital equipment, parts, and services.
  3. [3]
    Our History - Henry Schein
    Since 1932, Henry Schein, Inc. has grown to become a global leader in delivering health care solutions for 1 million customers worldwide.
  4. [4]
    Our Company - Henry Schein
    Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology.
  5. [5]
    Henry Schein Announces Strategic Investment by KKR, Board ...
    Jan 29, 2025 · Preliminary revenue in the fourth quarter totaled $3.2 billion, bringing revenue for the full year of 2024 to $12.7 billion.
  6. [6]
    Henry Schein Reports Second Quarter 2025 Financial Results
    Aug 5, 2025 · The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein ...
  7. [7]
    Ethisphere Names Henry Schein as One of the 2025 World's Most ...
    Mar 11, 2025 · Recognized since 2012, Henry Schein is one of three honorees in the Healthcare Products industry. In 2025, 136 honorees were recognized, ...
  8. [8]
    Henry Schein Named to FORTUNE® Magazine's 'Change the World ...
    Sep 25, 2024 · Henry Schein was recognized for its innovative emergency preparedness and response strategy in support of health care professionals, systems, ...<|control11|><|separator|>
  9. [9]
    History of Henry Schein, Inc. – FundingUniverse
    Henry Schein, a pharmacist, and his wife Esther founded the eponymous company in 1932 as a corner drugstore in the Woodside community of New York ...Missing: 1930s 1940s
  10. [10]
    Henry Schein celebrates its 90 th anniversary - Dental Tribune
    Nov 28, 2022 · MELVILLE, N.Y., US: Just over 90 years ago, the shop bell of a humble storefront pharmacy in Queens rang for the very first time.Missing: 1930s | Show results with:1930s
  11. [11]
    Henry Schein History: Founding, Timeline, and Milestones - Zippia
    1964. In 1964 a federal prosecutor filed a criminal complaint against Schein, who was charged with selling bottles containing counterfeit Dexedrine capsules ...
  12. [12]
    Millions of Fake Dexedrine Pills Sold - The New York Times
    Mr. Schein allegedly sold bottles containing 250 counterfeit Dexedrine sulfate Spansule capsules, identical in price ($50), form and packaging with the genuine ...Missing: outcome | Show results with:outcome
  13. [13]
    Member Spotlight: Henry Schein Celebrates 90 Years Delivering ...
    Dec 5, 2022 · Henry Schein became the first organization within the industry to fully automate the distribution cycle in 1984, and in 1990 we began to expand ...
  14. [14]
    Henry Schein to Ring the Nasdaq Stock Market Opening Bell
    Dec 14, 2020 · Henry Schein to Ring the Nasdaq Stock Market Opening Bell ... In the initial public offering in 1995, Henry Schein raised $72.8 million .
  15. [15]
    From Small Beginnings to a Company With Millions in Sales
    Jun 30, 1996 · Henry Schein reported sales of $616 million. The company went public in November. Since 1990, it has grown at a compounded annual rate of 22 percent.Missing: pivot 1940s
  16. [16]
    Henry Schein Inc | Encyclopedia.com
    Henry Schein, a pharmacist, and his wife Esther founded the eponymous company in 1932 as a corner drugstore in the Woodside community of New York ...
  17. [17]
    Henry Schein: Your dentist's biggest supplier - Fortune
    Nov 13, 2014 · Henry Schein operates in 28 countries and continues to expand its reach, including a recent investment in Japan, which has the world's ...Missing: 2000s- 2010s
  18. [18]
    Henry Schein Revenue 2011-2025 | HSIC - Macrotrends
    Henry Schein annual revenue for 2024 was $12.673B, a 2.71% increase from 2023. · Henry Schein annual revenue for 2023 was $12.339B, a 2.44% decline from 2022.Missing: 1960s growth
  19. [19]
    Dental Practice Management Software Market 2019-2025
    Jan 23, 2020 · Under this collaboration, CareCredit's financing tool has been integrated into Henry Schein's dental practice management software solutions. The ...
  20. [20]
    Henry Schein (HSIC) - Revenue - Companies Market Cap
    Henry Schein's current revenue (TTM) is $12.77 Billion USD. In 2024, the revenue was $12.67 Billion USD, and in 2023, it was $12.33 Billion USD.
  21. [21]
    Henry Schein at a Glance
    2024 gross sales of $6.7 billion · Increasing penetration with existing customers; Greater penetration of specialty markets ; 2024 gross sales of $4.1 billion.
  22. [22]
    [PDF] 2024 CARES REPORT - Henry Schein
    net zero 2050 (working toward our emissions reduction targets), supply chain and circularity (focusing on water.Missing: shortages | Show results with:shortages
  23. [23]
    Dental Supplies and Equipment - Henry Schein
    We're proud to say that 99% of our orders are processed and shipped within the same business day, with 9 in 10 arriving at your practice the next day—or sooner.Dental Equipment · Henry Schein TechCentral · Dental · Browse SuppliesMissing: war boom
  24. [24]
    Why Choose Henry Schein
    With 90+ years of experience, 300000+ products and 99% same-day shipping, Henry Schein is the trusted choice for dental supplies, dental equipment and more.<|separator|>
  25. [25]
    Henry Schein Creates Value For Customers And Shareholders
    Oct 11, 2021 · leading share (37%) of the global dental supply market · growth in medical supply and software segments · vast sales and distribution network ...
  26. [26]
    [PDF] Henry Schein Overview Q2 2025
    Aug 5, 2025 · Market share represents Henry Schein estimates and is based on 12-month data through Q4 2024. Only global dental distributor and solutions ...
  27. [27]
    Henry Schein Inc. - Company Profile Report - IBISWorld
    Their largest market share is in the Dental Equipment Dealers industry, where they account for an estimated 32.8% of total industry revenue. Company Details.Missing: advantages | Show results with:advantages<|control11|><|separator|>
  28. [28]
    About Henry Schein Medical - Medical Supplies Distributor ‍
    Henry Schein's deep history leads from humble roots to the Fortune 500. 1932. Founded as a storefront pharmacy in Queens, NY 2 Team Schein Members (TSMs) ...
  29. [29]
    Our Capabilities - Henry Schein Medical ‍
    Working with Henry Schein Supply Chain Technology, customers can implement customized budgets, approval routing, packing slips, invoices, and inventory ...Settings · Quality Management · Our Medical Suppliers
  30. [30]
    Delivering Excellence: Henry Schein Global Services - YouTube
    Mar 13, 2019 · Henry Schein is a health care solutions company powered by people and technology. Through our supply chain solutions, we have a 99% fill ...
  31. [31]
    Global Operations - Henry Schein
    Global Operations. Henry Schein Inc. proudly serves practitioners in over 190 countries/regions around the world. Please select your country/region:.
  32. [32]
    Henry Schein Acquires Majority Interest in Prism Medical Products ...
    Jan 5, 2021 · Henry Schein, Inc. acquires majority interest in Prism Medical Products and enters the home medical supply market.
  33. [33]
    Henry Schein Completes Acquisition of Acentus
    Jan 15, 2025 · The Acentus transaction follows Henry Schein's acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in ...Missing: 2000 | Show results with:2000
  34. [34]
    [PDF] The key to security ...
    The Henry Schein Medical Supply Chain Technology Team offers web-based tools to support secure procurement, compliant storage, and eco-friendly disposal of ...
  35. [35]
    Henry Schein One: Henry Schein Dental Software for Seamless ...
    Patients expect a modern experience. With 24/7 scheduling, online reputation management, and personalized outreach, we help attract and keep patients with ease.Dental Solutions · Contact Henry Schein One · Academic Solutions · Support
  36. [36]
    Dentrix Ascend – Dental Practice Management Software
    Dentrix Ascend is a cloud-based dental practice management software for managing schedules, records, claims, and more, with real-time syncing.Dentrix Ascend · Launch And Grow · Game Changing Features
  37. [37]
    Henry Schein Dental - Practice Management Software
    Learn how Henry Schein One's connected practice management software simplifies dental practice marketing, patient engagement and management.
  38. [38]
    Henry Schein One Announces Enhancement of Its axiUm Dental ...
    May 11, 2021 · Henry Schein One Announces Enhancement of Its axiUm Dental Software by Integrating Dental and Medical Patient Records ; North America and ; Europe ...
  39. [39]
    EDS Powered by Henry Schein One
    Integrated with +40 PMS Systems. Simplify your claims processing and payments using the unified EDS dashboard while data flows back into your practice ...Eds Powered By Henry Schein... · Integrated Revenue... · What Your Pms Lacks, Eds...
  40. [40]
    Effortless Patient Billing and Payment Processing for Better Cash Flow
    Automate billing and payment processes to save time, reduce errors, and prevent revenue loss while improving your cash flow.Billing And Payment... · What's Included? · What Customers Are Saying
  41. [41]
    How Henry Schein One Helped Their Customers Survive a Digital ...
    Dec 10, 2024 · Henry Schein One has been aggressively modernizing its software processes, tools, and patterns and building out their technical teams.Missing: 2023 recovery
  42. [42]
    Henry Schein One Offers Cybersecurity Solutions Provided by N-able
    Sep 23, 2024 · Henry Schein One today announced the availability of new cybersecurity solution, Adlumin Managed Detection and Response (MDR), provided by N-able.Missing: post- 2023 recovery modernization<|separator|>
  43. [43]
    Dental Data and Analytics Solutions | Henry Schein One
    Our versatile platform enables integration and interoperability with your preferred vendors. · Flexible and scalable, our platform grows with you.Missing: standards | Show results with:standards
  44. [44]
    Authorized Dentrix & Dentrix Ascend Integrations | Henry Schein One
    Through its integration with Henry Schein One, Podium automatically syncs patient data to enable seamless review invitations, two-way text messaging, and ...
  45. [45]
    Henry Schein and Henry Schein One Launch 'Linkit', Enabling ...
    Aug 26, 2025 · Henry Schein One, a leader in dental software, empowers dentists to focus on patient care, ensuring practice success. With its simple and ...Missing: key achievements
  46. [46]
    Promoting Clinical Interoperability - HL7 - Dentrix Enterprise
    Easily share data with other providers and medical systems with Dentrix Enterprise, which uses the international, trusted Health Level Seven - HL7 standards.<|control11|><|separator|>
  47. [47]
    Unlocking the Power of Integration: How the Henry Schein One API ...
    Aug 27, 2024 · The Henry Schein One API acts as a central integration hub, enabling DSOs to seamlessly connect their tech stack.Missing: globalization 2020
  48. [48]
    Henry Schein to spin off animal health, merge it with Vets First Choice
    Apr 23, 2018 · Henry Schein says spinning off and merging the animal health business will allow it to focus more on the dental and medical supply businesses. " ...
  49. [49]
    Henry Schein Spin-off Quick Summary - Stock Spinoff Investing
    Nov 25, 2021 · On April 23, 2018, Henry Schein (HSIC) unexpectedly announced that it would be spinning off its Animal Health business in a tax-free transaction ...
  50. [50]
    Henry Schein Completes Spin-Off Of Global Animal Health Business
    Feb 8, 2019 · Based on 2017 pro-forma sales of approximately $9.0 billion (excluding the $3.6 billion contribution of Animal Health ), the Company's revenue ...
  51. [51]
    Henry Schein To Spin Off And Merge Animal Health Business - Forbes
    Jan 9, 2019 · HSIC will spin-off its animal health business and merge it with Vets First Choice on February 4, 2019. The combined company will be re-branded as Covetrus, Inc.
  52. [52]
    Henry Schein to spin off veterinary business
    Apr 23, 2018 · “This merger creates an enhanced value chain that connects the veterinarian, the manufacturer and the pet owner through insights and analytics ...<|control11|><|separator|>
  53. [53]
    Henry Schein and Vets First Choice Announce New Name of the ...
    Dec 20, 2018 · The transaction is expected to be completed in the first quarter of 2019. The new company, Covetrus, will be a global, technology-enabled animal ...
  54. [54]
    Animal Health Spin-off - SEC.gov
    On February 7, 2019 (the “Distribution Date”), we completed the separation (the “Separation”) and subsequent merger (“Merger”) of our animal health business ( ...
  55. [55]
    Discontinued Operations - SEC.gov
    In connection with the completion of the Animal Health Spin-off, we entered into a transition services agreement with Covetrus under which we have agreed to ...
  56. [56]
    Henry Schein - Wikipedia
    Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's ...
  57. [57]
    Henry Schein Completes Acquisition of a Majority Interest in Shield ...
    Henry Schein announced the agreement to acquire Shield Healthcare on August 3, 2023. Headquartered in Valencia, Calif., Shield Healthcare had 2022 net sales of ...
  58. [58]
    Financials - Quarterly Results - Henry Schein, Inc. - Investor Relations
    Henry Schein Reports First Quarter 2025 Financial Results ; 122,243,683 outstanding on March 29, 2025 and. 124,155,884 outstanding on December 28, 2024.
  59. [59]
    Schein restructures, including layoffs, to save up to $100M
    Aug 8, 2024 · Henry Schein announced that it is restructuring the company, including conducting an undisclosed number of layoffs, in the hopes of saving the company up to $ ...<|control11|><|separator|>
  60. [60]
    Henry Schein Restructures for Growth, Expects Strong 2025 ...
    Feb 25, 2025 · Henry Schein has launched the 2025-2027 BOLD+1 Strategic Plan, expecting 2025 to serve as the foundation for long-term earnings growth.
  61. [61]
    Henry Schein Announces Completion of Strategic Investment by ...
    May 16, 2025 · May 16, 2025- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...Missing: 2020-2025 | Show results with:2020-2025<|separator|>
  62. [62]
    Henry Schein Medical Expands SolutionsHub with Colaborate
    Sep 9, 2025 · Henry Schein Medical's integration of Colaborate into its SolutionsHub represents a strategic expansion of its laboratory services ecosystem.
  63. [63]
    TDSC.com, Powered by Henry Schein, Announces New Affiliate ...
    Mar 17, 2025 · TDSC.com, Powered by Henry Schein, Announces New Affiliate Partnership with the Pennsylvania Dental Association. March 17, 2025. Download ...Missing: 2020-2025 | Show results with:2020-2025
  64. [64]
    BlackCat Ransomware Group Claims Responsibility for Attack on ...
    Nov 8, 2023 · Henry Schein confirmed on October 15, 2023, that it had experienced a cybersecurity incident, which was detected on October 14, 2023. The ...<|separator|>
  65. [65]
    Henry Schein discloses data breach a year after ransomware attack
    Henry Schein has finally disclosed a data breach following at least two back-to-back cyberattacks in 2023 by the BlackCat Ransomware gang.
  66. [66]
    EX-99.1 - SEC.gov
    Henry Schein has determined that the practice management software used by its clients has not been disrupted. The Company has engaged outside cybersecurity and ...Missing: 2023 | Show results with:2023
  67. [67]
    Henry Schein Confirms 166,000 Individuals Affected By October ...
    Oct 25, 2024 · Henry Schein confirmed in an October 15, 2023, announcement that it had been forced to take some of its systems offline to contain a cyberattack ...Missing: modernization | Show results with:modernization
  68. [68]
    Data breach confirmed by Henry Schein | SC Media
    Oct 25, 2024 · Major U.S. healthcare solutions provider Henry Schein has confirmed that 166,432 individuals had their personal information exfiltrated in ...Missing: details | Show results with:details
  69. [69]
    Henry Schein expects cyber incident costs to continue in 2024
    Feb 27, 2024 · The company reported a $350 million to $400 million reduction in Q4 sales due to the incident, which forced it to take some systems offline.
  70. [70]
    Henry Schein Reports Second Quarter 2024 Financial Results and ...
    Aug 6, 2024 · ... recovery from the cyber incident late last year. Internal sales for the quarter decreased 2.4%, which includes a 0.5% decrease from lower ...Missing: attack | Show results with:attack
  71. [71]
    Slow cyberattack recovery impacts Henry Schein Q2 sales, profits
    Aug 14, 2024 · As a result of sluggish sales and the slower recovery from the Henry Schein cyberattack, the company is taking a restructuring charge.Missing: modernization | Show results with:modernization
  72. [72]
    Henry Schein confirms data breach, details impact of cyberattack
    Nov 13, 2023 · The Henry Schein cyberattack exposed sensitive financial information of customers and suppliers and is expected to slow sales growth.<|separator|>
  73. [73]
    Henry Schein's slow recovery from cyber incident hits Q2 results
    Aug 7, 2024 · Henry Schein said Tuesday the recovery from a cyber incident that hit the company late last year has been slower than anticipated.Missing: modernization | Show results with:modernization
  74. [74]
    Activist investor Ananym Capital pushes for changes at Henry ...
    Nov 18, 2024 · Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, ...
  75. [75]
    Activist Ananym calls for cost cuts at Henry Schein. What to expect
    Nov 23, 2024 · Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits. Published Sat, Nov 23 20247:47 AM EST.
  76. [76]
    BUZZ-Henry Schein climbs on Ananym Capital's push for changes
    ... Henry Schein HSIC.O rise 6.2% to $73.09. ** Activist investor Ananym Capital Management is urging Henry Schein to refresh its board, cut ...
  77. [77]
    Activist Ananym plans to launch proxy fight at Henry Schein, sources ...
    Jan 22, 2025 · Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein.
  78. [78]
    IN-DEPTH: New activists join the fray in 2024 - Diligent
    Feb 14, 2025 · According to its website, Ananym elects to pursue discussions with leadership as well as deploying a variety of traditional activist techniques ...
  79. [79]
    Activist Ananym plans Henry Schein proxy fight over leadership ...
    Jan 24, 2025 · Activist hedge fund Ananym Capital Management is preparing to launch a proxy fight at dental and medical distributor Henry Schein.<|control11|><|separator|>
  80. [80]
    [PDF] Q1 2025 Review of Shareholder Activism - Barclays Investment Bank
    Apr 15, 2025 · Note: All data is for campaigns conducted globally by activists at companies with market capitalizations greater than $500 million at time of ...
  81. [81]
    With its stake in Henry Schein, KKR pushes shared ownership of ...
    Jan 29, 2025 · KKR had been amassing shares in Henry Schein, but partnered with the company after it faced a campaign by the activist investor Ananym Capital ...
  82. [82]
    KKR expands stake in Henry Schein, secures board seats to ...
    The investment comes amid growing pressure from activist investor Ananym Capital Management, which is pushing for a leadership transition, cost-cutting measures ...
  83. [83]
    KKR takes 12% stake in Henry Schein - Modern Healthcare
    Jan 29, 2025 · The medical products company has been subject of an activist campaign by Ananym Capital Management, which was pushing the company to cut ...
  84. [84]
    Healthcare firms see growing activist investor involvement ... - Reuters
    Aug 20, 2025 · Activist hedge fund Starboard Value in October 2024 called for management accountability for the company's underperformance. This month, ...
  85. [85]
    Henry Schein Cares Foundation
    The Henry Schein Cares Foundation harnesses the global reach of one of the world's leading solutions companies for health care professionals.<|separator|>
  86. [86]
    CARES Package Program - Henry Schein
    The Henry Schein CARES Package is a turn-key selection of six donated product kits geared towards Healthcare Heroes and their missions to Help Health Happen in ...
  87. [87]
    Henry Schein Cares Opens Applications for its Global Student ...
    Oct 1, 2025 · its Henry Schein Cares Global Student Outreach Program. This ... Founded in 1932 by Henry and Esther Schein, our Company has a rich history rooted ...
  88. [88]
    [PDF] 2024 CARES REPORT - Henry Schein
    In 2024 alone, the program supplied more than $11 million in dental and medical products to more than 125 nonprofit clinics and NGO partners. 0.76 net-zero.
  89. [89]
    [PDF] 2023 CARES REPORT - Henry Schein
    Through our. Practice Green initiative, we are offering products, solutions, and resources for our suppliers and customers to build and enhance more sustainable.
  90. [90]
    Henry Schein Releases its 2023 CARES Report
    Aug 5, 2024 · Henry Schein Cares, the company's global corporate citizenship program, aims to drive positive change through its 5 pillars: Catalyzing health ...
  91. [91]
    Henry Schein Details Progress in 2023 CARES Report ... - ESG Today
    Jul 31, 2024 · The CARES Report highlights Henry Schein's efforts to promote responsible business practices and create value for each of our stakeholders.
  92. [92]
    Henry Schein Opens Henry Schein Cares ... - Henry Schein, Inc.
    Henry Schein Opens Henry Schein Cares Foundation 2024 Relief Fund and Commits Up to $500,000 in Cash and Essential Health Care Supplies to Support the Southeast ...
  93. [93]
    Emergency Preparedness and Disaster Relief - Henry Schein
    Henry Schein provides a toll-free emergency phone number (1-800-999-9729) for customers who have been affected by disasters to help them reopen their practices ...
  94. [94]
    Henry Schein contributes to relief efforts in response to Hawaii ...
    The Company and the Henry Schein Cares Foundation are seeding a 2023 Disaster Relief Fund with a $25,000 donation and will match employee contributions up ...
  95. [95]
    Henry Schein Strengthens Emergency Preparedness and Recovery ...
    Sep 26, 2024 · For more than 20 years, Henry Schein has been strengthening emergency preparedness and supporting relief efforts worldwide through nonprofit and ...
  96. [96]
    Henry Schein Provides Seed Funding To MedShare's Disaster ...
    New Fund Will Enable MedShare to Expedite the Shipment of Medical Supplies and Equipment to Disaster-Affected Areas Throughout the World.